ClinicalTrials.Veeva

Menu

Identification of Cerebrospinal Fluid With Injeq IQ-Needle During Paediatric Lumbar Puncture

I

Injeq

Status

Completed

Conditions

Pediatric Lumbar Puncture

Treatments

Device: Injeq IQ-Needle

Study type

Interventional

Funder types

Industry

Identifiers

NCT02792660
INJ-SPINE-02

Details and patient eligibility

About

This is clinical feasibility study on the device performance with paediatric patients. The main objective is to validate the performance of investigational device in distinguishing and identifying the cerebrospinal fluid (CSF) inside the subarachnoid space during a lumbar puncture on paediatric patients.

Enrollment

40 patients

Sex

All

Ages

Under 18 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children whose diagnosis or treatment plan requires lumbar puncture to acquire a CSF sample.
  • Consent from the parents

Exclusion criteria

  • Being a high risk patient (as determined by the investigator)
  • Any contraindication to a common lumbar puncture apply also in the investigation

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

Injeq IQ-Needle
Experimental group
Description:
Lumbar puncture is performed using Injeq IQ-Needle
Treatment:
Device: Injeq IQ-Needle

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems